Global InformationÀÌ Á¦°øÇÏ°í ÀÖ´Â Á¦³×¸¯ ÀǾàÇ°(Generics), ¹ÙÀÌ¿À½Ã¹Ð·¯(Biosimilar), ¹ÙÀÌ¿Àº£ÅÍ(Biobetter) °ü·Ã º¸°í¼¿¡¼´Â ÇöÀç¿Í ÇâÈÄÀÇ Á¦³×¸¯ ÀǾàÇ° ½ÃÀå ȯ°æ ºÐ¼® Á¤º¸¸¦ ÀüÇص帮°í ÀÖ½À´Ï´Ù. ¶Ç ƯÇã ¸¸·á ´ëÃ¥°ú ÀǾàÇ° ¼ö¸íÁֱ⠰ü¸®, ½ÃÀå ÁøÃâ ±âȸ, ½ÇÀû »óÈ£ºñ±³ µîÀÇ Á¤º¸µµ È®ÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù.
º£Æ®³²ÀÇ Á¦³×¸¯ ÀǾàÇ° ½ÃÀå Æò°¡ : ¿ëµµº°, À¯Çüº°, ºê·£µåº°, Åõ¿©°æ·Îº°, À¯Åëä³Îº°, Áö¿ªº°, ±âȸ, ¿¹Ãø(2017-2031³â)
Vietnam Generic Drugs Market Assessment, By Application, By Type, By Brand, By Route of Administration, By Distribution Channel, By Region, Opportunities and Forecast, 2017-2031F
¹ßÇà 2024³â 09¿ù
°¡°Ý
US $ 3,300
£Ü 4,426,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå ±Ô¸ð Á¶»ç : ¾à¹° Á¾·ùº°, ÀûÀÀÁõº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)
Global Biosimilar Market Size Study, by Drug Class, by Indication and Regional Forecasts 2022-2032
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 4,950
£Ü 6,639,000 (ºÎ°¡¼¼ º°µµ)
|
¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼® : ÀûÀÀÁõº°, ¾à¹° À¯Çüº°, Áö¿ªº° - »ê¾÷ ¿¹Ãø(2024-2031³â)
Biosimilars Market Size, Share, Growth Analysis, By Indication (Oncology, Inflammatory & Autoimmune Disorders), Drug Type (Monocional Antibodies, Insulin), By Region - Industry Forecast 2024-2031
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 5,300
£Ü 7,108,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÇè ¹× °³¹ß ¼ºñ½º ½ÃÀå ±Ô¸ð Á¶»ç : À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)
Global Biosimilar Testing and Development Services Market Size study, by Type, by End User and Regional Forecasts 2022-2032
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 4,950
£Ü 6,639,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ Àν¶¸° ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå : ±Ô¸ð Á¶»ç, À¯Çüº°, ÀûÀÀÁõº°, À¯Åëä³Îº°, Áö¿ªº° ¿¹Ãø(2024-2032³â)
Global Insulin Biosimilar Market Size study, by Type, by Indication, by Distribution Channel and Regional Forecasts 2024-2032
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 4,950
£Ü 6,639,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ºê·£µå Á¦³×¸¯ ½ÃÀå ±Ô¸ð Á¶»ç : Á¦Ç° À¯Çüº°, Åõ¿© °æ·Îº°, ÀûÀÀÁõº°, À¯Åë ä³Îº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)
Global Branded Generics Market Size Study, by Product, by Drug Type, by Route of Administration, by Indication, by Distribution Channel and Regional Forecasts 2022-2032
¹ßÇà 2024³â 07¿ù
°¡°Ý
US $ 4,950
£Ü 6,639,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå : ¾àÁ¦ Ŭ·¡½ºº°, Ä¡·á À¯Çüº°, À¯Åë ä³Îº°, Áö¿ªº°
Biosimilars Market, By Drug Class, By Therapy Type, By Distribution Channel, By Geography
¹ßÇà 2024³â 07¿ù
°¡°Ý
US $ 4,500
£Ü 6,035,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå
Biosimilars
¹ßÇà 2024³â 07¿ù
°¡°Ý
US $ 5,600
£Ü 7,511,000 (ºÎ°¡¼¼ º°µµ)
|
ÀϺ»ÀÇ Á¦³×¸¯ ÀǾàÇ° ½ÃÀå : »ê¾÷ µ¿Çâ, Á¡À¯À², ±Ô¸ð, ¼ºÀå, ±âȸ ¿¹Ãø(2024-2032³â)
Japan Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032
¹ßÇà 2024³â 07¿ù
°¡°Ý
US $ 3,699
£Ü 4,961,000 (ºÎ°¡¼¼ º°µµ)
|
Àν¶¸° À¯»ç ¼ºÀåÀÎÀÚ ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2034³â)
Insulin-like Growth Factors Market (Type: Mechano Growth Factor, Somatomedin C, and IGF 1; and End-user: Hospitals and Medical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
¹ßÇà 2024³â 06¿ù
°¡°Ý
US $ 5,795
£Ü 7,772,000 (ºÎ°¡¼¼ º°µµ)
|
Àν¶¸° ÁÖ»ç º¸Á¶±â±¸ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : Á¦Ç°º°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)
Insulin Injection Aids Market Size, Share & Trends Analysis Report By Product (Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids), By End-use, By Region, And Segment Forecasts, 2024 - 2030
¹ßÇà 2024³â 06¿ù
°¡°Ý
US $ 5,950
£Ü 7,980,000 (ºÎ°¡¼¼ º°µµ)
|
Á¦³×¸¯ ÀǾàÇ° ½ÃÀå : À¯Çüº°, Åõ¿© °æ·Îº°, ÀûÀÀÁõº°, À¯Å뺰 - ¼¼°è ¿¹Ãø(2024-2030³â)
Generic Drugs Market by Type (Simple Generic, Specialty Generic), Route of Administration (Inhalable, Injectable, Oral), Indication, Distribution - Global Forecast 2024-2030
¹ßÇà 2024³â 06¿ù
°¡°Ý
US $ 4,949
£Ü 6,638,000 (ºÎ°¡¼¼ º°µµ)
|
Á¦³×¸¯ ÁÖ»çÁ¦ ½ÃÀå : Á¦Ç°º°, À¯Çüº°, ¿ëµµº°, À¯Åëä³Îº° - ¼¼°è ¿¹Ãø(2024-2030³â)
Generic Injectables Market by Product (Large Molecule Injectables, Small Molecule Injectables), Type (Cytokines, Insulin, Monoclonal Antibodies), Application, Distribution Channel - Global Forecast 2024-2030
¹ßÇà 2024³â 06¿ù
°¡°Ý
US $ 4,949
£Ü 6,638,000 (ºÎ°¡¼¼ º°µµ)
|
´Ùº£Æ÷¿¡Æ¾ ¾ËÆÄ ½ÃÀå : Àü´Þ ¹æ¹ý, ¿ëµµ ¹× ÃÖÁ¾ »ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2024-2030³â)
Darbepoetin Alfa Market by Mode of Delivery (Intravenous, Subcutaneous), Application (Cancer, Chronic Kidney Disease), End User - Global Forecast 2024-2030
¹ßÇà 2024³â 06¿ù
°¡°Ý
US $ 4,949
£Ü 6,638,000 (ºÎ°¡¼¼ º°µµ)
|
¼ÓÈ¿¼º Àν¶¸° ½ÃÀå : ¾à¹°º°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
Short-Acting Insulin Market, By Drug, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
¹ßÇà 2024³â 06¿ù
°¡°Ý
US $ 3,250
£Ü 4,359,000 (ºÎ°¡¼¼ º°µµ)
|
Àν¶¸° ÀúÇ×¼º - ½ÃÀå ÀλçÀÌÆ®, ¿ªÇÐ ¹× ½ÃÀå ¿¹Ãø(2034³â)
Insulin Resistance - Market Insight, Epidemiology, and Market Forecast - 2034
¹ßÇà 2024³â 06¿ù
°¡°Ý
US $ 7,950
£Ü 10,663,000 (ºÎ°¡¼¼ º°µµ)
|
Á¾¾çÇÐ¿ë ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå - ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø, ¾à¹° À¯Çüº°, ¾Ï À¯Çüº°, À¯Åë ä³Îº°, Áö¿ªº°, °æÀï»çº°(2019-2029³â)
Oncology Biosimilars Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Drug Class, By Type of Cancer, By Distribution Channel, By Region and Competition, 2019-2029F
¹ßÇà 2024³â 05¿ù
°¡°Ý
US $ 4,900
£Ü 6,572,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ Á¦³×¸¯ ÁÖ»çÁ¦ ½ÃÀå
Generic Injectables
¹ßÇà 2024³â 05¿ù
°¡°Ý
US $ 5,450
£Ü 7,310,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ÈíÀÔ ¹× ºñ° ½ºÇÁ·¹ÀÌ Á¦³×¸¯ ÀǾàÇ° ½ÃÀå
Inhalation and Nasal Spray Generic Drugs
¹ßÇà 2024³â 05¿ù
°¡°Ý
US $ 4,950
£Ü 6,639,000 (ºÎ°¡¼¼ º°µµ)
|
Á¦³×¸¯ ÀǾàÇ° ½ÃÀå - ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø : À¯Çüº°, ¿ëµµº°, ¾à¹°Àü´Þº°, Çüź°, À¯·¡º°, À¯Åë ä³Îº°, Áö¿ªº°, °æÀﺰ(2019-2029³â)
Generic Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Drug Delivery, By Form, By Source, By Distribution Channel, By Region and Competition, 2019-2029F
¹ßÇà 2024³â 05¿ù
°¡°Ý
US $ 4,900
£Ü 6,572,000 (ºÎ°¡¼¼ º°µµ)
|
¹ÙÀÌ¿À½Ã¹Ð·¯ Àν¶¸° ½ÃÀå : Áö¿ªº°(ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«) - ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2024-2031³â)
Biosimilar Insulin Market by Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
¹ßÇà 2024³â 04¿ù
°¡°Ý
US $ 4,900
£Ü 6,572,000 (ºÎ°¡¼¼ º°µµ)
|
¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå : Á¦Ç° À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° - ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2031³â)
Biosimilars Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
¹ßÇà 2024³â 04¿ù
°¡°Ý
US $ 4,900
£Ü 6,572,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ Àν¶¸° ½ÃÀå : ºÎ¹®º° ¿¹Ãø(2024-2030³â)
Insulin Market by Drug (Biologic, Biosimilar), Type (Intermediate-acting Insulin, Long-acting Insulin, Premixed Insulin), Application - Global Forecast 2024-2030
¹ßÇà 2024³â 04¿ù
°¡°Ý
US $ 4,949
£Ü 6,638,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ÈíÀÔ ¹× ºñ° ½ºÇÁ·¹ÀÌ Á¦³×¸¯ ÀǾàÇ° ½ÃÀå : ÀûÀÀÁõº°, ¿¬·ÉÃþº°, ¾àÁ¦ Ŭ·¡½ºº°, ·çÆ®º°, À¯Åë ä³Îº° ¿¹Ãø(2024-2030³â)
Inhalation & Nasal Sprays Generic Drugs Market by Indication (Allergic Rhinitis, Asthma, COPD), Age Group (Adults, Children 2 to 5, Children 6 to 12), Class, Route, Distribution Channel - Global Forecast 2024-2030
¹ßÇà 2024³â 04¿ù
°¡°Ý
US $ 4,949
£Ü 6,638,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ºê·£µå Á¦³×¸¯ ½ÃÀå : Á¦Ç° À¯Çü, ¾àÁ¦ À¯Çü, Åõ¿© °æ·Î, ÀûÀÀÁõ, À¯Åë ä³Îº° ¿¹Ãø(2024-2030³â)
Branded Generics Market by Product (Trade Named Generics, Value-Added), Drug Type (Alkylating Agents, Anti-depressants, Anti-epileptics), Route of Administration, Indication, Distribution Channel - Global Forecast 2024-2030
¹ßÇà 2024³â 04¿ù
°¡°Ý
US $ 4,949
£Ü 6,638,000 (ºÎ°¡¼¼ º°µµ)
|